The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors

被引:452
作者
Gräler, MH
Goetzl, EJ
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA
关键词
receptor internalization; calcium signaling; lymphocyte; immunity; transplantation;
D O I
10.1096/fj.03-0910fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FTY720 is an immunosuppressant that reduces circulating levels of naive lymphocytes by increasing their localization and sequestration in secondary lymphoid organs. It is considered to be an agonist for sphingosine 1-phosphate (S1P) G protein-coupled receptors (GPCRs) after phosphorylation at micromolar concentrations. We now describe its nonagonist and noncompetitive inhibitory activity at low nanomolar concentrations for types 1 and 5 S1P-GPCRs and of moderate potency for type 2 S1P-GPCRs. FTY720 blocks S1P signaling through S1P(1,2,5) by inducing their internalization and intracellular partial degradation without affecting S1P(3) or S1P(4). S1P-R internalization is maximal several hours after only seconds of incubation with FTY720 at 37degreesC and washing, and continues for days before recovery of surface expression and functions. The timing and extent of S1P-R internalization are highly dependent on FTY720 concentration. FTY720 is therefore an S1P-GPCR-selective and noncompetitive inhibitor with a unique mechanism of action.
引用
收藏
页码:551 / +
页数:22
相关论文
共 41 条
  • [1] An SZ, 1998, J CELL BIOCHEM, P147
  • [2] Bohler T, 2000, Transpl Int, V13 Suppl 1, pS311, DOI 10.1007/s001470050350
  • [3] The immune modulator FTY720 targets sphingosine 1-phosphate receptors
    Brinkmann, V
    Davis, MD
    Heise, CE
    Albert, R
    Cottens, S
    Hof, R
    Bruns, C
    Prieschl, E
    Baumruker, T
    Hiestand, P
    Foster, CA
    Zollinger, M
    Lynch, KR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21453 - 21457
  • [4] FTY720: Dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects
    Brinkmann, V
    Wilt, C
    Kristofic, C
    Nikolova, Z
    Hof, RP
    Chen, S
    Albert, R
    Cottens, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3078 - 3080
  • [5] FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity
    Brinkmann, V
    Lynch, KR
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (05) : 569 - 575
  • [6] FTY720: Altered lymphocyte traffic results in allograft protection.
    Brinkmann, V
    Pinschewer, DD
    Feng, L
    Chen, S
    [J]. TRANSPLANTATION, 2001, 72 (05) : 764 - 769
  • [7] Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073
  • [8] FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines
    Chen, S
    Bacon, KB
    Garcia, G
    Liao, R
    Pan, ZK
    Sullivan, SK
    Nakano, H
    Matsuzawa, A
    Brinkmann, V
    Feng, L
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3057 - 3063
  • [9] FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing
    Chiba, K
    Yanagawa, Y
    Kataoka, H
    Kawaguchi, T
    Ohtsuki, M
    Hoshino, Y
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1230 - 1233
  • [10] Chiba K, 1998, J IMMUNOL, V160, P5037